PCN172 - COST-EFFECTIVENESS ANALYSIS OF ALECTINIB IN UNTREATED ALK-REARRANGED NSCLC ITALIAN PATIENTS
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.255
https://www.valueinhealthjournal.com/article/S1098-3015(18)33555-1/fulltext
Section Title :
Section Order :
1893
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33555-1&doi=10.1016/j.jval.2018.09.255